Abstract: The present invention relates to methods of treating viral infections including COVID-19 and compositions with a combination of (i) an inhibitor of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) and (ii) an inhibitor of transmembrane serine proteinase 2 (TMPRSS-2).
Type:
Application
Filed:
December 14, 2023
Publication date:
June 20, 2024
Applicant:
AcuraStem, Inc.
Inventors:
Justin K. ICHIDA, Matthew STREMLAU, Hongyan ZHOU